Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries

被引:20
作者
Gårdsvoll, H
van Zonneveld, AJ
Holm, A
Eldering, E
van Meijer, M
Dano, K
Pannekoek, H
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands
[2] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[3] Royal Vet & Agr Univ, Dept Chem, DK-1871 Copenhagen, Denmark
关键词
phage display; plasminogen activator inhibitor 1; peptide; peptide library;
D O I
10.1016/S0014-5793(98)00742-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Large random hexa- and decapenta-peptide libraries were constructed and displayed on the surface of the filamentous phagemid pComb8. Fanning of the hexa-peptide library on immobilized plasminogen activator inhibitor 1 (PAI-1) specifically selected a minor fraction of concatemers, indicating that binding to PAI-1 requires an extended amino acid sequence. Accordingly, the decapenta-peptide library exclusively yielded PAI-1 binding peptides of 15 amino acid residues. None of these phage-bound peptides prevented the interaction between PAI-1 and its target serine protease urokinase (u-PA), To isolate peptides that block the interaction between PAI-1 and U-PA, phages bound to immobilized PAI-1 were eluted by incubation with u-PA. Remarkably, this procedure resulted in elution of a unique phage type that harbors a concatemer of decapentamers, consisting of 49 amino acid residues with no obvious similarity to the primary sequence of PAI-1 or u-PA. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 25 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   THROMBOLYSIS AND REOCCLUSION IN EXPERIMENTAL JUGULAR-VEIN AND CORONARY-ARTERY THROMBOSIS - EFFECTS OF A PLASMINOGEN-ACTIVATOR INHIBITOR TYPE 1-NEUTRALIZING MONOCLONAL-ANTIBODY [J].
BIEMOND, BJ ;
LEVI, M ;
CORONEL, R ;
JANSE, MJ ;
TENCATE, JW ;
PANNEKOEK, H .
CIRCULATION, 1995, 91 (04) :1175-1181
[4]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[5]   PLATELETS AND THROMBOLYTIC THERAPY [J].
COLLER, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :33-42
[6]   DISPLAY OF BIOLOGICALLY-ACTIVE PROTEINS ON THE SURFACE OF FILAMENTOUS PHAGES - A CDNA CLONING SYSTEM FOR SELECTION OF FUNCTIONAL GENE-PRODUCTS LINKED TO THE GENETIC INFORMATION RESPONSIBLE FOR THEIR PRODUCTION [J].
CRAMERI, R ;
SUTER, M .
GENE, 1993, 137 (01) :69-75
[7]   DEVELOPMENT OF VENOUS OCCLUSIONS IN MICE TRANSGENIC FOR THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE [J].
ERICKSON, LA ;
FICI, GJ ;
LUND, JE ;
BOYLE, TP ;
POLITES, HG ;
MAROTTI, KR .
NATURE, 1990, 346 (6279) :74-76
[8]  
Fay WP, 1997, BLOOD, V90, P204
[9]   BRIEF REPORT - COMPLETE DEFICIENCY OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DUE TO A FRAME-SHIFT MUTATION [J].
FAY, WP ;
SHAPIRO, AD ;
SHIH, JL ;
SCHLEEF, RR ;
GINSBURG, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1729-1733
[10]  
FRANDSEN TL, 1998, IN PRESS DRUG NEWS P